Maxim Integrated Products (MXIM) Reports In-Line Q2 EPS, Offers Q3 Guidance

Maxim Integrated Products (NASDAQ: MXIM) reported Q2 EPS of $0.32, in-line with the analyst estimate of $0.32. Revenue for the quarter came in at $510.8 million versus the consensus estimate of $505.08 million.

GUIDANCE:

Maxim Integrated Products sees Q3 2016 EPS of $0.38-$0.44, versus the consensus of $0.46. Maxim Integrated Products sees Q3 2016 revenue of $535-575 million, versus the consensus of $568.46 million.

• Gross Margin: 57% to 60% GAAP (60% to 63% excluding special items)

For earnings history and earnings-related data on Maxim Integrated Products (MXIM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c